79 related articles for article (PubMed ID: 24077234)
1. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors.
Lenko V; Bialesova L; Macejova D; Bujdak P; Breza J; Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):316-24. PubMed ID: 24077234
[TBL] [Abstract][Full Text] [Related]
2. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
4. Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention.
Brtko J
Cent Eur J Public Health; 2007 Mar; 15(1):3-6. PubMed ID: 17491551
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
6. The retinoid receptors.
Pemrick SM; Lucas DA; Grippo JF
Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
[TBL] [Abstract][Full Text] [Related]
7. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
8. The retinoid receptors.
Pemrick SM; Lucas DA; Grippo JF
Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
[TBL] [Abstract][Full Text] [Related]
9. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
[TBL] [Abstract][Full Text] [Related]
10. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
11. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
[TBL] [Abstract][Full Text] [Related]
12. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
14. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
15. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification.
Pijnappel WW; Hendriks HF; Folkers GE; van den Brink CE; Dekker EJ; Edelenbosch C; van der Saag PT; Durston AJ
Nature; 1993 Nov; 366(6453):340-4. PubMed ID: 8247127
[TBL] [Abstract][Full Text] [Related]
16. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
Brtko J; Thalhamer J
Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
Toma S; Isnardi L; Riccardi L; Bollag W
Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
[TBL] [Abstract][Full Text] [Related]
18. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Zou CP; Hong WK; Lotan R
Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
[TBL] [Abstract][Full Text] [Related]
20. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
